Recommendations: Antiplatelet Agents (3)
Recommendations for the use of antiplatelet agents1 are summarized in three slides Slide 3 of 3 Use aspirin therapy (75-162 mg/day) as a secondary prevention strategy in those with diabetes with a history of CVD (A) For patients with CVD and documented aspirin allergy, clopidogrel (75 mg/day) should be used (B) Combination therapy with ASA (75-162 mg/day) and clopidogrel (75 mg/day) is reasonable for up to a year after an acute coronary syndrome (B) Clopidogrel has been demonstrated to reduce CVD events in diabetic individuals2 It is recommended as adjunctive therapy in the first year after an acute coronary syndrome or as alternative therapy in aspirin-intolerant patients82References American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(suppl 1):S33-S34. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002;90:625-628.